Compare Novavax Inc (NVAX) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Southern Copper Corp — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Southern Copper Corp trades at $187.06 (market cap $146.07B). The key difference: Southern Copper Corp is far larger — about 112.4× Novavax Inc's market cap, and Southern Copper Corp pays a 2.28% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | SCCO | |
|---|---|---|
Market Cap | $1.30B | $146.07B |
Sector | Health | Basic Materials |
52-Week High | $11.19 | $218.85 |
52-Week Low | $6.22 | $90.54 |
Enterprise Value | $800.50M | $148.12B |
Dividend Yield | — | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
